APPLICATION
ANDA217461
TYPE
ANDA
ORIGINAL APPROVAL
2026-07-09
LATEST ACTION
2026-07-09
ROUTE
INTRAMUSCULAR, INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
MAGNESIUM SULFATEPrescription
MAGNESIUM SULFATE 10GM/20ML (500MG/ML) · SOLUTION · INTRAMUSCULAR, INTRAVENOUS
MAGNESIUM SULFATEPrescription
MAGNESIUM SULFATE 1GM/2ML (500MG/ML) · SOLUTION · INTRAMUSCULAR, INTRAVENOUS
MAGNESIUM SULFATEPrescription
MAGNESIUM SULFATE 25GM/50ML (500MG/ML) · SOLUTION · INTRAMUSCULAR, INTRAVENOUS
MAGNESIUM SULFATEPrescription
MAGNESIUM SULFATE 5GM/10ML (500MG/ML) · SOLUTION · INTRAMUSCULAR, INTRAVENOUS
Approval history
2026-07-09UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.